These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25372252)

  • 41. Randomized, observer-blind, split-face study to compare the irritation potential of 2 topical acne formulations over a 14-day treatment period.
    Ting W
    Cutis; 2012 Aug; 90(2):91-6. PubMed ID: 22988653
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Double-blind, randomized, vehicle-controlled clinical trial of once-daily benzoyl peroxide/clindamycin topical gel in the treatment of patients with moderate to severe rosacea.
    Breneman D; Savin R; VandePol C; Vamvakias G; Levy S; Leyden J
    Int J Dermatol; 2004 May; 43(5):381-7. PubMed ID: 15117375
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of benzoyl peroxide 5% clindamycin combination gel versus adapalene 0.1% on quality of life in patients with mild to moderate acne vulgaris: a randomized single-blind study.
    Guerra-Tapia A
    J Drugs Dermatol; 2012 Jun; 11(6):714-22. PubMed ID: 22648218
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Overall results of the BEST study following treatment of patients with mild to moderate acne.
    Weiss J; Shavin J; Davis MW
    Cutis; 2003 Feb; 71(2 Suppl):10-7. PubMed ID: 12630670
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clindamycin phosphate 1.2%-benzoyl peroxide (5% or 2.5%) plus tazarotene cream 0.1% for the treatment of acne.
    Dhawan SS; Gwazdauskas J
    Cutis; 2013 Feb; 91(2):99-104. PubMed ID: 23513559
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of topical benzoyl peroxide/clindamycin versus topical clindamycin and vehicle in the reduction of Propionibacterium acnes.
    Leyden JJ
    Cutis; 2002 Jun; 69(6):475-80. PubMed ID: 12078851
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A randomized, investigator-blinded trial to assess the antimicrobial efficacy of a benzoyl peroxide 5%/ clindamycin phosphate 1% gel compared with a clindamycin phosphate 1.2%/tretinoin 0.025% gel in the topical treatment of acne vulgaris.
    Jackson JM; Fu JJ; Almekinder JL
    J Drugs Dermatol; 2010 Feb; 9(2):131-6. PubMed ID: 20214175
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The BEST study: results according to prior treatment.
    Rodriguez D; Davis MW
    Cutis; 2003 Feb; 71(2 Suppl):27-34. PubMed ID: 12630672
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Study design and selection criteria in the BEST study.
    Rist T; Davis MW
    Cutis; 2003 Feb; 71(2 Suppl):5-9. PubMed ID: 12630669
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dermatopharmacology of a new combination gel formulation for the topical treatment of acne.
    Levy S
    Cutis; 2001 Feb; 67(2 Suppl):8-12. PubMed ID: 11236214
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Meta-analysis of randomized controlled trials using 5% benzoyl peroxide and clindamycin versus 2.5% benzoyl peroxide and clindamycin topical treatments in acne.
    Seidler EM; Kimball AB
    J Am Acad Dermatol; 2011 Oct; 65(4):e117-e119. PubMed ID: 21816505
    [No Abstract]   [Full Text] [Related]  

  • 52. Skin tolerability and efficacy of combination therapy with hydrogen peroxide stabilized cream and adapalene gel in comparison with benzoyl peroxide cream and adapalene gel in common acne. A randomized, investigator-masked, controlled trial.
    Capizzi R; Landi F; Milani M; Amerio P
    Br J Dermatol; 2004 Aug; 151(2):481-4. PubMed ID: 15327558
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Letter to the editor: comparative efficacy and safety of clindamycin phosphate/benzoyl peroxide and adapalene/benzoyl peroxide in acne treatment: a systematic review and meta-analysis of randomized controlled trials.
    Sesgundo JA; Borra UR; Teslim AA; Hikal H; Qammar A; Adams D; Serag I
    Arch Dermatol Res; 2024 Sep; 316(8):595. PubMed ID: 39225838
    [No Abstract]   [Full Text] [Related]  

  • 54. A novel gel formulation of 0.25% tretinoin and 1.2% clindamycin phosphate: efficacy in acne vulgaris patients aged 12 to 18 years.
    Eichenfield LF; Wortzman M
    Pediatr Dermatol; 2009; 26(3):257-61. PubMed ID: 19706084
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Truncal acne vulgaris: the relative roles of topical and systemic antibiotic therapy.
    Del Rosso JQ
    J Drugs Dermatol; 2007 Feb; 6(2):148-51. PubMed ID: 17373173
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Benzoyl peroxide: enhancing antibiotic efficacy in acne management.
    Dutil M
    Skin Therapy Lett; 2010; 15(10):5-7. PubMed ID: 21076800
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clindamycin phosphate 1.2%- tretinoin 0.025% gel: vehicle characteristics, stability, and tolerability.
    Del Rosso JQ; Jitpraphai W; Bhambri S; Momin S
    Cutis; 2008 May; 81(5):405-8. PubMed ID: 18543590
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Improving treatment outcomes: tolerability of a fixed-combination clindamycin 1%-benzoyl peroxide 5% hydrating gel as monotherapy or in combination with a retinoid.
    Eichenfield L
    Cutis; 2009 Nov; 84(5 Suppl):12-7. PubMed ID: 19999188
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The tolerability profile of clindamycin 1%/benzoyl peroxide 5% gel vs. adapalene 0.1%/benzoyl peroxide 2.5% gel for facial acne: results of a randomized, single-blind, split-face study.
    Gonzalez P; Vila R; Cirigliano M
    J Cosmet Dermatol; 2012 Dec; 11(4):251-60. PubMed ID: 23174047
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prospective, open-label, comparative study of clindamycin 1%/benzoyl peroxide 5% gel with adapalene 0.1% gel in Asian acne patients: efficacy and tolerability.
    Ko HC; Song M; Seo SH; Oh CK; Kwon KS; Kim MB
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):245-50. PubMed ID: 19438817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.